SRCM
GILD icon

Signature Resources Capital Management’s Gilead Sciences GILD Stock Holding History

Signature Resources Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.8K Buy
260
+14
+6% +$1.84K 0.01% 196
2026
Q1 		$34.3K Buy
246
+59
+32% +$8.26K 0.02% 169
2025
Q4 		$23K Buy
187
+14
+8% +$1.7K 0.01% 199
2025
Q3 		$19.2K Sell
173
-5
-3% -$568 0.01% 214
2025
Q2 		$19.7K Buy
178
+35
+24% +$3.73K 0.01% 213
2025
Q1 		$16K Hold
143
– – 0.01% 177
2024
Q4 		$13.2K Hold
143
– – 0.01% 186
2024
Q3 		$12K Hold
143
– – 0.01% 194
2024
Q2 		$9.81K Hold
143
– – 0.01% 215
2024
Q1 		$11.6K Hold
143
– – 0.01% 187
2023
Q4 		$11.6K Buy
+143
New +$11.1K 0.01% 189

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Signature Resources Capital Management's GILD Position: Q2 2026 in Review

Signature Resources Capital Management increased its Gilead Sciences (GILD) stake by 5.7% in Q2 2026, buying an estimated $1.84K and bringing the position to 260 shares worth $32.8K. The position accounts for 0.01% of the portfolio, ranked #196.

Signature Resources Capital Management first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $34.3K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Signature Resources Capital Management held 260 shares of Gilead Sciences worth $32.8K as of Q2 2026.
  • Signature Resources Capital Management bought 14 Gilead Sciences shares in Q2 2026, an estimated $1.84K.
  • Gilead Sciences made up 0.01% of Signature Resources Capital Management's portfolio in Q2 2026, its #196 holding.
  • Signature Resources Capital Management first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • Signature Resources Capital Management's Gilead Sciences position peaked at $34.3K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Signature Resources Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.